Anthony S. Gibney - 17 Apr 2024 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role: Director
Signature: /s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol: CLSD
Transactions as of: 17 Apr 2024
Net transactions value: +$129,664
Form type: 4
Filing time: 19 Apr 2024, 09:45:06 UTC
Previous filing: 16 Apr 2024
Next filing: 21 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLSD	Common Stock	Purchase	$8,388	+6,710		$1.25	6,710	17 Apr 2024	Direct
transaction	CLSD	Common Stock	Purchase	$121,277	+93,290	+1390%	$1.30	100,000	18 Apr 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.249 to $1.38 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.249 to $1.38 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.